How we are using the discharge medicines service to help patients on high-risk medicines
The views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. The new discharge medicines service (DMS), introduced in England in February 2021, has the potential to deliver important patient safety benefi…
Published: 27 July 2021